username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
Upcoming Bioplasma gathering organized by IMAPAC to help facilitate the growth ...

Clicks:496 Date:07/17/13
Upcoming Bioplasma gathering organized by IMAPAC to help facilitate the growth and innovation of quality plasma products in Asia
 
 
Recognizing the region鈥檚 need to work towards self-sufficiency in plasman products, Bioplasma World Asia 2013 will bring together, for the second consecutive year, the Asian and international blood plasma community on 03-04 September 2013 at the Grand Hyatt, Bali. Plasma fractionators, blood centers, health authorities and other industry stakeholders will converge at this much awaited gathering to discuss strategic issues and explore opportunities within Asia-Pacific鈥檚 plasma therapeutics sector.
 
Asia faces a shortage in plasma and plasma products, with only 20% of the total world volume being fractionated here, despite comprising 60% of the world鈥檚 population. Several factors come into play, such as insufficient funding and a weak blood collection infrastructure. However, Asian countries have begun to make efforts in strengthening their capacity for plasma fractionation, and developments are underway.
 
Bioplasma World Asia 2013鈥檚 distinguished panel of speakers will share information and debate issues relating to the Asian plasma landscape, regulatory landscape, business strategies, market trends, and partnership opportunities to facilitate the development of the region鈥檚 plasma industry. Supported by the PPTA (Plasma Protein Therapeutics Association) and IPFA (International Plasma Fractionation Association), this event will be co-located with Asia鈥檚 first ever Bloodborne Pathogen Safety Workshop 鈥 a unique gathering bringing together regional and international stakeholders in the blood collection and transfusion sector to help safeguard the quality of collected blood.
 
Key speaking faculty for the Bioplasma 2013 event includes:
路 Dr. Russell Basser, Senior Vice President of Global Clinical Research & Development, CSL Benring, USA
路 Mr. Jan M. Bult, President and CEO, Plasma Protein Therapeutics Association (PPTA), USA
路 Pan Ruo-Wen, Senior Vice President, Hualan Biologicals, China
路 Dr. Ranjit S. Ajmani, Chief Executive Officer, PlasmaGen BioSciences, Bangalore, India
路 Kim Young-ho, Managing Director, Overseas Business Division, Green Cross Corporation, Korea
路 Dr. Thierry Burnouf, Professor, Taipei Medical University, Taiwan
路 Jan Over, Strategic Affairs, Sanquin Plasma Products, The Netherlands
路 Dr. Wolfgang Teschner, Director of Plasma Product Developmet/Product Support Department, Baxter, Austria
路 Mr. Theo Evers, Senior Advisor, International Plasma Fractionation Association (IPFA), Amsterdam, Netherlands
路 Stephanie Gunn, Deputy General Manager, National Blood Authority, Australia
Dr. Yuyun SM Soerdarmono, Director of Central Blood Center, Indonesian Red Cross, Indonesia
路 Dr. Chandra Viswanathan, Senior Vice President, Reliance Life Sciences, India
路 Dr. Chris Shue, President and CEO, Shanghai Syndegen Biopharmaceutical Company, China
路 Dr. Pierre-François Falcou, Alliances Director, LFB Biomedicaments, France
路 Dr. Surinder Singh, Director, National Institute of Biologicals, India
路 Johan Prevot, Executive Director, International Patient Organisation for Primary Immunodeficiencies (IPOPI), Portugal
路 Eric Youssef, European Plasma Market Director, Merck Millipore
路 Jerry A. Holmberg, Director, Scientific Affairs, Novartis Vaccines and Diagnostics, Inc.
Here are some brief testimonials from the attendees of last year鈥檚 event: 鈥淰ery informative and helpful for me to understand the overview of plasma product in Asia!鈥 - Hua Zhang, Chief GMP Inspection, CCE, ShFDA, China. 鈥淕ood start! Looking forward to return!鈥 - K Y Tan, General Manager, Haemonetics, Hong Kong. 鈥淓xcellent content and great information on plasma products!鈥 - Sunil Saigal, Director, Consolidated Products, India.
 
For more information on the upcoming event, please contact Natasha Jiandani on Natasha.jiandani@imapac.com or call +65-6493-1871.
 
Related News>> more
  • TELSTAR HAS INTRODUCED ionHP BIODECONTAMINATION TECHNOLOGY FOR ASEPTIC SYSTEMS4/23/2014
  • ISPE Singapore Conference & Exhibition 2014 & Healthcare Facilities Asia4/17/2014
  • 5th CSHA Symposium: Structural Biology - From Atoms to Cells4/14/2014
  • RephiLe successfully presented at analytica 20144/10/2014
  • Biotech China Show Preview4/9/2014
  • Biotech China to Showcase Industrial Parks4/9/2014
  • CSHA 2014:Liver Metabolism, Diseases and Cancer4/3/2014
  • An Interview with Pall's Global Vaccine Market Manager Annelies Onraedt3/28/2014
  • 2nd Annual Single Cell Genomics and Transcriptomics Asia Congress3/28/2014
  • 4th Annual Next Generation Sequencing Asia Congress3/28/2014
  • advertisement

    Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙